×
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| Shyama Computronics and Servic | 0.70 | 0.19 | 0.61 | NA | 4.02 | 30.9 |
| Triochem Products Ltd., | 4.59 | 0.88 | NA | 3.60 | 0 | |
| LINCOLN PHARMACEUTICALS LTD. | 1555.22 | 207.69 | 1465.52 | 10.37 | 1,136 | 12.7 |
| Shree Ganesh Remedies Limited | 277.63 | 54.24 | 270.53 | 4.22 | 948 | 32.6 |
| KOPRAN LTD. | 726.84 | 74.07 | 719.38 | 1.53 | 892 | 18.8 |
Lincoln Pharmaceuticals ltd., with Security Code 531633, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 123.4 | 140.6 | 133.7 | 112.4 | 135.6 | 155.9 | 146.4 | 142.4 | 147.2 | 161.2 |
| Expenses | 106.6 | 111.7 | 107.0 | 95.9 | 114.9 | 124.8 | 116.8 | 124.1 | 124.6 | 132.8 |
| Operating Profit | 16.9 | 28.9 | 26.8 | 16.6 | 20.7 | 31.1 | 29.7 | 18.4 | 22.7 | 28.4 |
| OPM % | 13.7% | 20.56% | 20% | 14.76% | 15.28% | 19.97% | 20.25% | 12.9% | 15.43% | 17.6% |
| Other Income | 6.5 | 5.7 | 6.4 | 3.9 | 7.7 | 8.7 | 11.0 | 7.0 | 10.4 | 10.0 |
| Interest | 0.4 | 0.1 | 0.3 | 1.1 | 0.4 | 0.4 | 0.2 | 0.5 | 0.4 | 0.3 |
| Depreciation | 2.1 | 2.4 | 2.3 | 2.4 | 2.5 | 2.6 | 2.8 | 2.7 | 3.2 | 3.2 |
| Profit before tax | 20.9 | 32.0 | 30.5 | 17.0 | 25.4 | 36.9 | 37.7 | 22.2 | 29.5 | 34.8 |
| Tax % | 28.3% | 26% | 29.2% | 26% | 25.3% | 25% | 25.6% | 16.3% | 19.7% | 24.3% |
| Net Profit | 15.0 | 23.7 | 21.6 | 12.6 | 19.0 | 27.7 | 28.0 | 18.6 | 23.7 | 26.3 |
| EPS in Rs | 7.49 | 11.84 | 10.79 | 6.27 | 9.49 | 13.81 | 14 | 9.28 | 11.82 | 13.15 |
| Metrics | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 140.6 | 133.8 | 112.5 | 135.6 | 156.0 | 146.4 | 142.5 | 147.3 | 161.2 | 146.6 |
| Expenses | 111.7 | 107.0 | 95.8 | 114.9 | 124.8 | 116.8 | 124.1 | 124.6 | 132.8 | 122.9 |
| Operating Profit | 28.9 | 26.7 | 16.6 | 20.7 | 31.1 | 29.7 | 18.4 | 22.7 | 28.4 | 23.7 |
| OPM % | 20.6% | 20% | 14.8% | 15.3% | 20% | 20.3% | 12.9% | 15.4% | 17.6% | 16.1% |
| Other Income | 5.7 | 6.4 | 3.9 | 7.7 | 8.7 | 11.0 | 7.0 | 10.4 | 10.0 | 9.0 |
| Interest | 0.1 | 0.3 | 1.1 | 0.4 | 0.4 | 0.2 | 0.5 | 0.4 | 0.3 | 0.7 |
| Depreciation | 2.4 | 2.3 | 2.4 | 2.5 | 2.6 | 2.8 | 2.7 | 3.2 | 3.2 | 3.2 |
| Profit before tax | 32.1 | 30.5 | 17.0 | 25.4 | 36.9 | 37.7 | 22.2 | 29.5 | 34.8 | 28.7 |
| Tax % | 26% | 29.2% | 26% | 25.3% | 25% | 25.6% | 16.3% | 19.7% | 24.3% | 27.6% |
| Net Profit | 23.7 | 21.6 | 12.6 | 19.0 | 27.7 | 28.0 | 18.6 | 23.7 | 26.3 | 20.8 |
| EPS in Rs | 11 | 10 | 6 | 9 | 13 | 14 | 9 | 11 | 13 | 10 |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 11% |
| 5 Years: | 10% |
| 3 Years: | 11% |
| TTM: | 9% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 23% |
| 5 Years: | 15% |
| 3 Years: | 14% |
| TTM: | 2% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 22% |
| 5 Years: | 26% |
| 3 Years: | 23% |
| 1 Year: | -23% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 11% |
| 5 Years: | 10% |
| 3 Years: | 11% |
| TTM: | 9% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 25% |
| 5 Years: | 14% |
| 3 Years: | 14% |
| TTM: | 2% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 22% |
| 5 Years: | 26% |
| 3 Years: | 23% |
| 1 Year: | -23% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|